Correction: NADPH Oxidase 4 Deficiency Reduces Aquaporin-2 mRNA Expression in Cultured Renal Collecting Duct Principal Cells via Increased PDE3 and PDE4 Activity.

Correction: NADPH Oxidase 4 Deficiency Reduces Aquaporin-2 mRNA Expression in Cultured Renal Collecting Duct Principal Cells via Increased PDE3 and PDE4 Activity.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3937386

Similar Items

Correction: NADPH Oxidase 4 Deficiency Reduces Aquaporin-2 mRNA Expression in Cultured Renal Collecting Duct Principal Cells via Increased PDE3 and PDE4 Activity
Published: (2014-01-01)

Differential expression and function of PDE8 and PDE4 in effector T cells: Implications for PDE8 as a drug target in inflammation.
by: Amanda G. Vang, et al.
Published: (2016-08-01)

Expression Pattern of PDE4B, PDE4D, and SFRP5 Markers in Colorectal Cancer
by: Mateo Bevanda, et al.
Published: (2024-07-01)

Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding region
by: Chloe Gulliver, et al.
Published: (2023-10-01)

A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice
by: Séguin Rosanne, et al.
Published: (2009-05-01)

Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
by: Andrew Blauvelt, et al.
Published: (2023-11-01)

PDE4 as a target in preterm labour
by: Hervé Roxane, et al.
Published: (2007-06-01)

PDE4-Mediated cAMP Signalling
by: Bracy A. Fertig, et al.
Published: (2018-01-01)

A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition.
by: Didem Demirbas, et al.
Published: (2013-01-01)

Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems
by: Dakshinamurthy Sivakumar, et al.
Published: (2021-05-01)

NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in mice
by: Felix Renaudin, et al.
Published: (2023-02-01)

Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
by: Min Kyu Park, et al.
Published: (2025-01-01)

CDP840: a novel inhibitor of PDE-4.
by: Perry, M, et al.
Published: (1998)

Short PDE4 Isoforms as Drug Targets in Disease
by: Elka Kyurkchieva, et al.
Published: (2023-07-01)

Nonlinear compressive reduced basis approximation for PDE’s
by: Cohen, Albert, et al.
Published: (2023-09-01)

Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
by: Jonathan E. Phillips
Published: (2020-03-01)

Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development
by: Gülru Kayık, et al.
Published: (2017-01-01)

Effects of PDE4 Pathway Inhibition in Rat Experimental Stroke
by: Fan Yang, et al.
Published: (2014-08-01)

Differential Effects of PDE4 Inhibitors on Cortical Neurons and T-Lymphocytes
by: Ryo Hirose, et al.
Published: (2008-01-01)

Inhibition of NADPH oxidase 2 improves cognitive abilities by modulating aquaporin-4 after traumatic brain injury in mice
by: Ruixing He, et al.
Published: (2023-11-01)

Recent topics in nonlinear PDE /
by: Masayasu Mimura
Published: (1984)

Computational methods for PDE in mechanics /
by: D'Acunto, Berardino
Published: (2004)

Convexity of solutions to elliptic PDE's
by: Benyam Mebrate, et al.
Published: (2024-09-01)

Plan of Development of the Education - PDE
by: João Josué Silva Filho
Published: (2008-04-01)

PDE4 inhibitors: potential protective effects in inflammation and vascular diseases
by: Tianfei Fan, et al.
Published: (2024-06-01)

An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
by: Letizia Crocetti, et al.
Published: (2022-08-01)

The regulatory role of PDE4B in the progression of inflammatory function study
by: Yue Su, et al.
Published: (2022-10-01)

Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma
by: Matija Snuderl, et al.
Published: (2018-07-01)

Novel PDE4 inhibitors derived from Chinese medicine forsythia.
by: Tiffany A Coon, et al.
Published: (2014-01-01)

Design and synthesis of novel indole-quinoxaline hybrids to target phosphodiesterase 4 (PDE4)
by: Bethala Jawahar Luther, et al.
Published: (2019-12-01)

A phosphodiesterase 4 (PDE4) inhibitor, amlexanox, reduces neuroinflammation and neuronal death after pilocarpine-induced seizure
by: Hyun Wook Yang, et al.
Published: (2024-07-01)

A certified reduced basis approach to PDE-constrained optimization
by: Qian, Elizabeth Yi
Published: (2017)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
by: Nikoleta Pavlaki, et al.
Published: (2018-01-01)

PDE 4 inhibitors: The use of molecular cloning in the design and development of novel drugs
by: Hughes, B, et al.
Published: (1997)

Heterocyclic Nitrogen Compounds as Potential PDE4B Inhibitors in Activated Macrophages
by: Simona Todisco, et al.
Published: (2024-08-01)

Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice
by: Abigail Boyd, et al.
Published: (2021-12-01)

PDE4B Is a Homeostatic Regulator of Cyclic AMP in Dendritic Cells
by: Amy M. Chinn, et al.
Published: (2022-03-01)

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
by: Dave Singh, et al.
Published: (2019-08-01)

Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis
by: Guo Yuh-Cherng, et al.
Published: (2010-06-01)

The role of NADPH Oxidase 4 in Iraqi Osteoporosis Patients
by: ola H Fadhil, et al.
Published: (2024-09-01)